Generic drugs may gain from stronger Democrats: WSJ
681991
The newly empowered Democrats' vow to cut healthcare costs might spell bad news for the brand-name pharmaceutical industry, but could provide new momentum for generic drug rivals, the Wall Street Journal reported on its Web site on Tuesday.
473365
Merck & Co. Inc.  shares could  rise to $70 by 2010 if the drugmaker continues to deliver on  its promise of double-digit earnings growth, Barron's said in  its October 29 edition.
736352
Pfizer Inc.  on Wednesday said third-quarter earnings rose on higher sales of cholesterol and arthritis drugs, but the company cautioned that 2005 results will likely be hurt by generic competition for four other popular medicines.
455943
Insured and wealthy Americans are more likely than needy patients to get the billions of dollars in free drug samples distributed by pharmaceutical companies to win patient and doctor loyalty, a study released on Wednesday said.
439056
The generics drugmaker forecasts its 2008 financials.
212519
The pharmaceutical industry is expected to face pressure to curb rising prescription-drug costs no matter which candidate wins next week's U.S. presidential election.
550598
It sounded simple enough on the campaign trail: Free the government to negotiate lower drug prices and use the savings to plug a big gap in Medicare's new prescription-drug benefit. But as Democrats prepare to take control of Congress, they are struggling to keep that promise without wrecking a...
549121
A U.S. Food and Drug Administration preliminary analysis found a level of heart-attack risk with GlaxoSmithKline Plc'sdiabetes drug Avandia similar to what was reported in a study earlier this week, the agency confirmed on Friday.
246189
Private equity firm The Carlyle Group is mulling a bid for the generics business of Germany's Merck KGaA , a unit worth at least 4 billion euros ($5.3 billion), a source close to the process said.
181860
Platforms have the potential to develop multiple drugs for a company.
732377
The companies decide to play nice over generic versions of two of Pfizer's drugs.
14335
Drug stocks took another hit Friday, a day after a veteran Food and Drug Administration researcher said that five drugs currently on the market needed closer scrutiny for possible safety risks.
371171
Some U.S. Senate Republicans voiced  reservations on Thursday about a bill designed to stop drug  makers from striking deals to restrict the introduction of  cheaper generic drugs.
379179
Two months into Wal-MartÂs drug program, it is unclear whether offering $4 generic drugs is drawing new customers into the companyÂs stores.
434277
The market might overlook the drug maker's promising programs.
733825
Nonbinding offers for the generics business of Merck KGaA , worth at least 4 billion euros ($5.3 billion), are due on Monday, a source close to the sale process told Reuters, confirming a newspaper report.
254545
An Indian drug maker, Ranbaxy Laboratories, said it had submitted a bid for the generics unit of the German drug maker Merck but did not disclose how much it was offering. Analysts say Merckâs generics unit could be worth as much as 5 billion euros ($6.6 billion). Merck said last month that it had started contacting companies that might be interested in acquiring its generics drugs unit. Two companies, Ranbaxy and the Actavis Group of Iceland, have publicly expressed an interest. Merck is based in Darmstadt.